• Novo Nordisk average return on equity for 2023 was 83.81, a 15.47% increase from 2022.
• Novo Nordisk average return on equity for 2022 was 72.58, a 0.43% increase from 2021.
• Novo Nordisk average return on equity for 2021 was 72.89, a 0.41% decline from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.